Stricker-Krongrad Alain, Shoemake Catherine R, Liu Jason, Brocksmith Derek, Bouchard Guy
a Sinclair Research Center , Columbia , MO , USA and.
b Sinclair BioResources , Columbia , MO , USA.
Cutan Ocul Toxicol. 2017 Jun;36(2):105-113. doi: 10.1080/15569527.2016.1178277. Epub 2016 May 10.
The use of miniature swine as a non-rodent species in safety assessment has continued to expand for over a decade and their use has become routine, particularly in pharmacology as a model for human integumentary diseases. Translational preclinical swine study data are now favorably compared and contrasted to human data, and miniature swine models provide important information in dermal safety assessment and skin pharmacology. For example, the miniature swine model has been well-accepted for cutaneous absorption and toxicity studies due to swine integument being morphologically and functionally similar to human skin. Subsequently, this model is important to dermal drug development programs, and it is the animal model of choice for assessment of dermal absorption, local tolerance and systemic toxicity following dermal exposures. In conclusion, the miniature swine model has an important role to play in the safety assessment of pharmaceutical products and in multiple aspects of human dermal drug development.
在安全性评估中,将小型猪作为非啮齿类动物使用已有十多年,且其使用已成为常规操作,尤其是在药理学领域,作为人类皮肤疾病的模型。目前,临床前猪的转化研究数据已与人类数据进行了有益的比较和对比,小型猪模型在皮肤安全性评估和皮肤药理学方面提供了重要信息。例如,由于猪的皮肤在形态和功能上与人类皮肤相似,小型猪模型在皮肤吸收和毒性研究中已被广泛接受。因此,该模型对皮肤药物开发项目很重要,是评估皮肤接触后的皮肤吸收、局部耐受性和全身毒性的首选动物模型。总之,小型猪模型在药品安全性评估和人类皮肤药物开发的多个方面都发挥着重要作用。